S&P 500 7,568.92 +0.36%
Nasdaq 25,372.01 +0.83%
S&P/TSX 35,532.28 −0.75%
Apple 331.90 −1.90%
Nvidia 206.69 +2.29%
Microsoft 520.99 +2.74%
Shopify 200.19 −8.02%
Royal Bank 285.42 −0.28%
CAD/USD 0.7164 +0.17%
PRE-MKT · 06:05 ET
Market ClerkRecap
Wed Nov 4 · pre-market3 signals on Nov 3175 insider buys this week · $365.2MCIRO short report next: Nov 15The week ahead

LENZ

LENZ Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
3.50
+0.45 +14.75%
USD · Nov 3, 06:40 p.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose LENZ in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
RA Capital Management, L.P. and 3 related0.2%
SCHEDULE 13D/A · filed Nov 2 · investment · EDGAR ↗
BlackRock Portfolio Management LLC5.2%
SCHEDULE 13G · filed Oct 27 · passive · EDGAR ↗
Millennium Management LLC and 2 related3.7%
SCHEDULE 13G/A · filed Oct 21 · passive · EDGAR ↗
FMR LLC and 1 related5.7%
SCHEDULE 13G/A · filed Sep 8 · passive · EDGAR ↗

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch LENZ. Know when insiders buy.
One email the day a filing lands. Free.